Literature DB >> 26884851

Regulator role of HPV E7 protein on miR-21 expression in cervical carcinoma cells and its functional implication.

Qingqin Kong1, Wenfeng Wang1, Ping Li1.   

Abstract

Cervical cancer is the second leading malignant tumor in women. Human papillomavirus 16 (HPV16) is one risk factor for cervical cancer, with its expressed E7 protein can facilitate the transformation of cervical epithelial cells. MicroRNA-21 (miR-21) is one important tumor growth regulatory factor involving in angiogenesis, tumor invasion and metastasis. This study thus aimed to investigate the role of high-risk HPV16 E7 protein in regulating miR-21 expression in cervical carcinoma and its related functions. Hela cells were transfected with pcDNA-HPV16 E7 expressing vectors. The expression level of E7 was determined by Western blotting, while miR-21 level was quantified by real-time PCR. The alternation of tumor cell proliferation is determined by transfecting miR-21 inhibitor into E7-overexpressing Hela cells. Cell apoptosis was studied by caspase-3 assay, while cell invasion was illustrated in Transwell chamber. The overexpression of HPV E7 protein facilitated the expression of miR-21, which potentiated Hela cell proliferation and invasion. The inhibition of miR-21 in E7-overexpressin Hela cells can inhibit both proliferation and invasion, but without significant effects on caspase-3 activity. HPV16 E7 protein can up-regulate host miR-21 expression, thus elevating cervical carcinoma cell growth, proliferation and invasion. Therefore, E7 protein is one critical factor in occurrence and progression of cervical carcinoma.

Entities:  

Keywords:  Cervical carcinoma; E7 protein; Herpes virus 16; MicroRNA; oncogenes

Mesh:

Substances:

Year:  2015        PMID: 26884851      PMCID: PMC4730064     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  21 in total

Review 1.  Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances.

Authors:  Nishant S Gandhi; Rakesh K Tekade; Mahavir B Chougule
Journal:  J Control Release       Date:  2014-09-07       Impact factor: 9.776

2.  The concordance of HPV DNA detection by Hybrid Capture 2 and careHPV on clinician- and self-collected specimens.

Authors:  Wen Chen; Jose Jeronimo; Fang-Hui Zhao; You-Lin Qiao; Melissa Valdez; Xun Zhang; Le-Ni Kang; Pooja Bansil; Proma Paul; Ping Bai; Roger Peck; Jing Li; Feng Chen; Mark H Stoler; Philip E Castle
Journal:  J Clin Virol       Date:  2014-10-07       Impact factor: 3.168

3.  Modeling age-specific cancer incidences using logistic growth equations: implications for data collection.

Authors:  Xing-Rong Shen; Rui Feng; Jing Chai; Jing Cheng; De-Bin Wang
Journal:  Asian Pac J Cancer Prev       Date:  2014

4.  Induction of apoptosis in HPV16 E7 transfected human keratinocyte by ALA-mediated photodynamic therapy.

Authors:  Fei Miao; Ting Lv; Yunfeng Zhang; Zheng Huang; Xiuli Wang; Hongwei Wang
Journal:  Photodiagnosis Photodyn Ther       Date:  2015-07-19       Impact factor: 3.631

5.  Clinical performance of hybrid capture 2 human papillomavirus testing for recurrent high-grade cervical/vaginal intraepithelial neoplasm in patients with an ASC-US Papanicolaou test result during long-term posttherapy follow-up monitoring.

Authors:  Andrea Diaz De Vivar; Marilyn Dawlett; Jian-Ping Wang; Annie Jack; Yun Gong; Gregg Staerkel; Ming Guo
Journal:  Arch Pathol Lab Med       Date:  2015-02       Impact factor: 5.534

6.  Performance of HPV DNA testing with hybrid capture 2 in triaging women with minor cervical cytologic abnormalities (ASC-US/LSIL) in Northern Thailand.

Authors:  Surapan Khunamornpong; Jongkolnee Settakorn; Kornkanok Sukpan; Jatupol Srisomboon; Prapaporn Suprasert; Sumalee Siriaunkgul
Journal:  Asian Pac J Cancer Prev       Date:  2014

7.  Clinical efficacy and failure pattern in patients with cervical esophageal cancer treated with definitive chemoradiotherapy.

Authors:  Peng Zhang; Mian Xi; Lei Zhao; Bo Qiu; Hui Liu; Yong-Hong Hu; Meng-Zhong Liu
Journal:  Radiother Oncol       Date:  2015-07-29       Impact factor: 6.280

Review 8.  MicroRNAs in colorectal cancer: from diagnosis to targeted therapy.

Authors:  Ayla Valinezhad Orang; Abolfazl Barzegari
Journal:  Asian Pac J Cancer Prev       Date:  2014

9.  Differential expression of miRNAs in colon cancer between African and Caucasian Americans: implications for cancer racial health disparities.

Authors:  Ellen Li; Ping Ji; Nengtai Ouyang; Yuanhao Zhang; Xin Yu Wang; Deborah C Rubin; Nicholas O Davidson; Roberto Bergamaschi; Kenneth R Shroyer; Stephanie Burke; Wei Zhu; Jennie L Williams
Journal:  Int J Oncol       Date:  2014-05-27       Impact factor: 5.650

Review 10.  MicroRNAs: promising new antiangiogenic targets in cancer.

Authors:  Sandra Gallach; Silvia Calabuig-Fariñas; Eloisa Jantus-Lewintre; Carlos Camps
Journal:  Biomed Res Int       Date:  2014-08-14       Impact factor: 3.411

View more
  9 in total

Review 1.  The human papillomavirus E7 oncoprotein as a regulator of transcription.

Authors:  William K Songock; Seong-Man Kim; Jason M Bodily
Journal:  Virus Res       Date:  2016-11-08       Impact factor: 3.303

2.  MicroRNA-21 and microRNA-155 promote the progression of Burkitt's lymphoma by the PI3K/AKT signaling pathway.

Authors:  Bo Han; Shuguo Wang; Hongguo Zhao
Journal:  Int J Clin Exp Pathol       Date:  2020-01-01

3.  MicroRNA-130a regulated by HPV18 E6 promotes proliferation and invasion of cervical cancer cells by targeting TIMP2.

Authors:  Shanlan Yin; Quanle Zhang; Yuhong Wang; Shaoru Li; Ruili Hu
Journal:  Exp Ther Med       Date:  2019-01-31       Impact factor: 2.447

Review 4.  microRNA-21: a key modulator in oncogenic viral infections.

Authors:  Guitian He; Juntao Ding; Yong'e Zhang; Mengting Cai; Jing Yang; William C Cho; Yadong Zheng
Journal:  RNA Biol       Date:  2021-03-22       Impact factor: 4.652

5.  Evaluation and clinical significance of cyclin-dependent kinase5 expression in cervical lesions: a clinical research study in Guangxi, China.

Authors:  Deng-Hua Pan; Mei-Lin Zhu; Xiao-Miao Lin; Xing-Gu Lin; Rong-Quan He; Yan-Xin Ling; Shi-Tao Su; Madushi Mihiranganee Wickramaarachchi; Yi-Wu Dang; Kang-Lai Wei; Gang Chen
Journal:  Eur J Med Res       Date:  2016-07-12       Impact factor: 2.175

Review 6.  The Role of MicroRNAs in the Metastatic Process of High-Risk HPV-Induced Cancers.

Authors:  Joana M O Santos; Sara Peixoto da Silva; Natália R Costa; Rui M Gil da Costa; Rui Medeiros
Journal:  Cancers (Basel)       Date:  2018-12-05       Impact factor: 6.639

7.  High-Risk Human Papillomavirus E7 Proteins Target PTPN14 for Degradation.

Authors:  Elizabeth A White; Karl Münger; Peter M Howley
Journal:  mBio       Date:  2016-09-20       Impact factor: 7.867

8.  MicroRNA-21 regulates the proliferation and apoptosis of cervical cancer cells via tumor necrosis factor-α.

Authors:  Lin Xu; Qian Xu; Xiwen Li; Xiaoling Zhang
Journal:  Mol Med Rep       Date:  2017-08-02       Impact factor: 2.952

Review 9.  The role of HPV-induced epigenetic changes in cervical carcinogenesis (Review).

Authors:  Martha Laysla Ramos Da Silva; Beatriz Helena Dantas Rodrigues De Albuquerque; Thales Araújo De Medeiros Fernandes Allyrio; Valéria Duarte De Almeida; Ricardo Ney De Oliveira Cobucci; Fabiana Lima Bezerra; Vania Sousa Andrade; Daniel Carlos Ferreira Lanza; Jenner Christian Veríssimo De Azevedo; Josélio Maria Galvão De Araújo; José Veríssimo Fernandes
Journal:  Biomed Rep       Date:  2021-05-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.